Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and durability in a cohort of HIV-1 positive patients treated with once and twice daily darunavir-based therapy (SCOLTA Project).
Menzaghi B, Ricci E, Carenzi L, Parruti G, Orofino G, Guastavigna M, Madeddu G, Maggi P, Di Biagio A, Corsi P, Penco G, De Socio G, Martinelli C, Vichi F, Celesia BM, Franzetti M, Grosso C, Molteni C, Bonfanti P, Quirino T. Menzaghi B, et al. Among authors: franzetti m. Biomed Pharmacother. 2013 May;67(4):293-8. doi: 10.1016/j.biopha.2012.12.005. Epub 2012 Dec 26. Biomed Pharmacother. 2013. PMID: 23433852 Clinical Trial.
IL-1 Receptor Antagonist Anakinra in the Treatment of COVID-19 Acute Respiratory Distress Syndrome: A Retrospective, Observational Study.
Franzetti M, Forastieri A, Borsa N, Pandolfo A, Molteni C, Borghesi L, Pontiggia S, Evasi G, Guiotto L, Erba M, Pozzetti U, Ronchetti A, Valsecchi L, Castaldo G, Longoni E, Colombo D, Soncini M, Crespi S, Maggiolini S, Guzzon D, Piconi S. Franzetti M, et al. J Immunol. 2021 Apr 1;206(7):1569-1575. doi: 10.4049/jimmunol.2001126. Epub 2021 Feb 5. J Immunol. 2021. PMID: 33547169 Free PMC article.
Characteristics and Clinical Implications of Carbapenemase-Producing Klebsiella pneumoniae Colonization and Infection, Italy.
Rossi M, Chatenoud L, Gona F, Sala I, Nattino G, D'Antonio A, Castelli D, Itri T, Morelli P, Bigoni S, Aldieri C, Martegani R, Grossi PA, Del Curto C, Piconi S, Rimoldi SG, Brambilla P, Bonfanti P, Van Hauwermeiren E, Puoti M, Gattuso G, Cerri C, Raviglione MC, Cirillo DM, Bandera A, Gori A; KPC-Kp Study Group. Rossi M, et al. Emerg Infect Dis. 2021 May;27(5):1416-1426. doi: 10.3201/eid2705.203662. Emerg Infect Dis. 2021. PMID: 33900910 Free PMC article.
Successful prolonged cefiderocol treatment of a chronic left pleural empyema caused by Pseudomonas aeruginosa in a patient affected by COVID-19: a case report.
Borghesi L, Viaggi V, Franzetti M, Montoli M, Mauri C, Moioli G, Benvenuti MR, Piconi S, Luzzaro F. Borghesi L, et al. Among authors: franzetti m. J Glob Antimicrob Resist. 2021 Dec;27:157-159. doi: 10.1016/j.jgar.2021.09.005. Epub 2021 Sep 22. J Glob Antimicrob Resist. 2021. PMID: 34562658 Free PMC article. No abstract available.
What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centres.
Comelli A, Genovese C, Lombardi A, Bobbio C, Scudeller L, Restelli U, Muscatello A, Antinori S, Bonfanti P, Casari S, Castagna A, Castelli F, Monforte AD, Franzetti F, Grossi P, Lupi M, Morelli P, Piconi S, Puoti M, Pusterla L, Regazzetti A, Rizzi M, Rusconi S, Zuccaro V, Gori A, Bandera A; ASP Lomb Study Group. Comelli A, et al. Antimicrob Resist Infect Control. 2022 Aug 29;11(1):108. doi: 10.1186/s13756-022-01152-5. Antimicrob Resist Infect Control. 2022. PMID: 36038903 Free PMC article.
Monoclonal antibodies against SARS-CoV-2 to prevent COVID-19 worsening in a large multicenter cohort.
Soria A, Graziano F, Ghilardi G, Lapadula G, Gasperina DD, Benatti SV, Quiros-Roldan E, Milesi M, Bai F, Merli M, Minisci D, Franzetti M, Asperges E, Chiabrando F, Pocaterra D, Pandolfo A, Zanini F, Lombardi D, Cappelletti A, Rugova A, Borghesi ML, Squillace N, Pusterla L, Piconi S, Morelli P, Querini PR, Bruno R, Rusconi S, Casari S, Bandera A, Franzetti F, Travi G, D'Arminio Monforte A, Marchetti G, Pan A, Castelli F, Rizzi M, Dentali F, Mallardo M, Rossi E, Valsecchi MG, Galimberti S, Bonfanti P. Soria A, et al. Among authors: franzetti m. Heliyon. 2024 Aug 13;10(16):e36102. doi: 10.1016/j.heliyon.2024.e36102. eCollection 2024 Aug 30. Heliyon. 2024. PMID: 39247344 Free PMC article.
97 results